A potent neutralizing antibody provides protection against SARS-CoV-2 Omicron and Delta variants via nasal delivery

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is still rapidly spreading worldwide. Many drugs and vaccines have been approved for clinical use show efficacy in the treatment and prevention of SARS-CoV-2 infections. However, the emergence of SARS-CoV-2 variants of concern (VOCs), such...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Xinghai, Zhang, Huajun, Li, Tingting, Chen, Shaohong, Luo, Feiyang, Zhou, Junhui, Zheng, Peiyi, Song, Shuyi, Wu, Yan, Jin, Tengchuan, Tang, Ni, Jin, Aishun, Yang, Chengyong, Cheng, Guofeng, Gong, Rui, Chiu, Sandra, Huang, Ailong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424799/
https://www.ncbi.nlm.nih.gov/pubmed/36042204
http://dx.doi.org/10.1038/s41392-022-01135-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9424799/
https://www.ncbi.nlm.nih.gov/pubmed/36042204
http://dx.doi.org/10.1038/s41392-022-01135-3

Ejemplares similares